Use of State Hospital Discharge Data to Assess the Morbidity From Rotavirus Diarrhea and to Monitor the Impact of a Rotavirus Immunization Program: A Pilot Study in Connecticut
- 1 September 1999
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 104 (3), 489-494
- https://doi.org/10.1542/peds.104.3.489
Abstract
Objectives.: Now that rotavirus vaccines have been licensed and recommended for routine immunization of US infants, there is an urgent need for data to assess the morbidity from rotavirus diarrhea and to monitor the impact of a rotavirus immunization program. In a pilot study, we have assessed the usefulness of state hospital discharge data on diarrhea in children to provide this information by examining data from Connecticut.Design.: Retrospective analysis of discharge records from acute care, nongovernmental hospitals in Connecticut.Patients.: Children 1 month through 4 years of age with a diarrhea-associated diagnosis listed on the discharge record.Setting.: Connecticut, 1987 through 1996.Results.: During the 10-year study period, a total of 11 324 diarrhea-associated hospitalizations (49.4 hospitalizations per 10 000 children) were reported. Diarrhea-associated hospitalizations peaked during February through April, especially among children 4 to 35 months of age. The seasonality and age distribution of diarrhea-associated hospitalizations of presumed noninfectious and viral etiologies resembled those of rotavirus-associated hospitalizations. During 1993 to 1996, rotavirus was coded for 10.4% of diarrhea-associated hospitalizations increasing from 8.6% in 1993 to 14.7% in 1996. The unadjusted median cost of a diarrhea-associated hospitalization during 1987 to 1996 and 1993 to 1996 was $1941 and $2428, respectively.Conclusions.: Diarrhea causes substantial morbidity in children from Connecticut. The winter seasonal peak of diarrhea-associated hospitalizations in children 4 to 35 months of age coinciding with the peak of rotavirus-specific hospitalizations suggests that rotavirus is an important contributor to the overall morbidity. Although our findings suggest incomplete coding of rotavirus cases, state hospital discharge data should provide sensitive and timely information to monitor the impact of a rotavirus immunization program in Connecticut.Keywords
This publication has 9 references indexed in Scilit:
- Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus VaccinePediatrics, 1998
- Epidemiology of diarrheal disease among children enrolled in four west coast health maintenance organizationsThe Pediatric Infectious Disease Journal, 1998
- Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code.The Journal of Infectious Diseases, 1998
- Efficacy of the Rhesus Rotavirus–Based Quadrivalent Vaccine in Infants and Young Children in VenezuelaNew England Journal of Medicine, 1997
- Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populationsThe Journal of Pediatrics, 1997
- Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritisThe Lancet, 1997
- Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirusThe Pediatric Infectious Disease Journal, 1996
- Impact of Rotavirus Infection at a Large Pediatric HospitalThe Journal of Infectious Diseases, 1990
- Use of Oral Fluid Therapy and Posttreatment Feeding Following Enteritis in Children in a Developed CountryPediatrics, 1985